Le Lézard
Classified in: Health
Subjects: CCA, FVT

Castlight Health to Announce Third Quarter 2018 Results


SAN FRANCISCO, Oct. 11, 2018 /PRNewswire/ -- Castlight Health, Inc. (NYSE: CSLT) will release its third quarter 2018 financial results on Tuesday, November 6, 2018, after the market closes. At 5:00 p.m. Eastern Time (ET), senior management will host a conference call to review the Company's financial performance.

Castlight Logo (PRNewsfoto/Castlight Health)

The live conference call will be available at (833) 238-7953. Please dial in at least five minutes before the scheduled start time to register. The call replay will be available for one week, starting at approximately 8:00 p.m. ET on November 6, 2018, at (800) 585-8367. The conference ID for the live call and replay is 8532429.

The live and archived webcast of the conference call will be available on the Investor Relations section of www.castlighthealth.com.

About Castlight Health
Castlight is on a mission to make it as easy as humanly possible to navigate healthcare and live happier, healthier, more productive lives. Our health navigation platform connects with hundreds of health vendors, benefits resources, and plan designs, giving rise to the world's first comprehensive app for all health needs. We guide individuals?based on their unique profile?to the best resources available to them, whether they are healthy, chronically ill, or actively seeking medical care. In doing so, we help companies regain control over rising healthcare costs and get more value from their benefits investments. Castlight revolutionized the healthcare sector with the introduction of data-driven price transparency tools in 2008 and the first consumer-grade wellbeing platform in 2012. Today, Castlight serves as the health navigation platform for millions of people and is a trusted partner to many of the largest employers in the world.

For more information, please visit www.castlighthealth.com. Follow us on Twitter and LinkedIn and Like us on Facebook.   

Investor Contact:
Gary J. Fuges, CFA
[email protected]

Copyright 2018 Castlight Health, Inc. Castlight Health® is the registered trademark of Castlight Health, Inc. Other company and product names may be trademarks of the respective companies with which they are associated.

 

SOURCE Castlight Health, Inc.


These press releases may also interest you

at 03:26
Calliditas Therapeutics AB , ("Calliditas") today announced that the global open-label extension (OLE) study to the Phase 3 NefIgArd study showed a treatment response consistent with the NefIgArd study across endpoints of urine protein to creatinine...

at 03:00
Flindr...

at 03:00
CSL Vifor and Travere Therapeutics, Inc., today announced that the European Commission has granted conditional marketing authorization (CMA) for FILSPARI (sparsentan) for the...

at 03:00
Tetra Pharm Technologies and Glysious are pleased to announce a strategic collaboration aimed at developing a ground-breaking transdermal drug delivery system complementing several of Tetra Pharm Technologies' pipeline candidates. The...

at 02:45
Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced financial results for the first quarter of fiscal year 2024....

at 02:25
SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders is pleased to announce a new partnership with Al Shirawi Healthcare solutions, a leading distributor of medical technologies...



News published on and distributed by: